Highlights and Quick Summary
- Weighted Average Shares Growth for the quarter ending June 30, 2023 was 15.78% (a 72.27% increase compared to previous quarter)
- Year-over-year quarterly Weighted Average Shares Growth increased by 1615.22%
- Annual Weighted Average Shares Growth for 2022 was 2.12% (a -99.16% decrease from previous year)
- Annual Weighted Average Shares Growth for 2021 was 253.54% (a -48.18% decrease from previous year)
- Annual Weighted Average Shares Growth for 2020 was 489.28% (a -617.1% decrease from previous year)
Visit stockrow.com/DYN
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical Weighted Average Shares Growth of Dyne Therapeutics, Inc.
Most recent Weighted Average Shares Growthof DYN including historical data for past 10 years.Interactive Chart of Weighted Average Shares Growth of Dyne Therapeutics, Inc.
Dyne Therapeutics, Inc. Weighted Average Shares Growth for the past 10 Years (both Annual and Quarterly)
| Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
|---|---|---|---|---|---|
| 2023 | 15.78% | 9.16% | – | – | – |
| 2022 | 3.09% | 0.92% | 0.9% | 4.3% | 2.12% |
| 2021 | 253.54% | 641.63% | 1789.19% | 464.94% | 253.54% |
| 2020 | 477.92% | -86.52% | -94.71% | -82.3% | 489.28% |
| 2019 | – | – | – | -94.47% | -94.62% |
| 2018 | – | – | – | – | 0.0% |
Business Profile of Dyne Therapeutics, Inc.
Sector: Healthcare
Industry: Biotechnology